The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations (2019)
Subjects: DOENÇAS DA JUNÇÃO NEUROMUSCULAR, PROTEÍNAS DE MATRIZ EXTRACELULARES, SINAPSE, MUTAÇÃO GENÉTICA, RECEPTORES ADRENÉRGICOS, AMINAS
ABNT
CRUZ, Pedro M. Rodriguez et al. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations. Brain, v. 142, p. 1547-1560, 2019Tradução . . Disponível em: https://doi.org/10.1093/brain/awz107. Acesso em: 13 nov. 2024.APA
Cruz, P. M. R., Cossins, J., Estephan, E. de P., Munell, F., Selby, K., Hirano, M., et al. (2019). The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations. Brain, 142, 1547-1560. doi:10.1093/brain/awz107NLM
Cruz PMR, Cossins J, Estephan E de P, Munell F, Selby K, Hirano M, Maroofin R, Mehrjardi MYV, Zanoteli E, Reed UC. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations [Internet]. Brain. 2019 ; 142 1547-1560.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/brain/awz107Vancouver
Cruz PMR, Cossins J, Estephan E de P, Munell F, Selby K, Hirano M, Maroofin R, Mehrjardi MYV, Zanoteli E, Reed UC. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations [Internet]. Brain. 2019 ; 142 1547-1560.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1093/brain/awz107